Paracetamol and Dermatop drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paracetamol (acetaminophen) and Dermatop (prednicarbate). Common drug interactions include stevens-johnson syndrome among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Paracetamol and Dermatop. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Paracetamol?

Paracetamol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 115,650 Paracetamol users. Check the latest studies of Paracetamol.

What is Dermatop?

Dermatop has active ingredients of prednicarbate. eHealthMe is studying from 356 Dermatop users. Check the latest studies of Dermatop.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

13 people who take Paracetamol and Dermatop together, and have interactions are studied.

Paracetamol and Dermatop drug interactions.

What are the common drug interactions of Paracetamol and Dermatop, by gender? *:

female:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  4. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

male:

  1. Abdominal pain
  2. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  3. Hyperthyroidism (over activity of the thyroid gland)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Myalgia (muscle pain)
  6. Myopia (difficult to see objects that are far away)
  7. Oral candidiasis (fungal infection of mouth)
  8. Oral herpes (viral infection of mouth)
  9. Upper respiratory tract infection
  10. Vision blurred

What are the common drug interactions of Paracetamol and Dermatop, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

50-59:

n/a

60+:

  1. Abdominal pain
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Hyperthyroidism (over activity of the thyroid gland)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Myalgia (muscle pain)
  6. Myopia (difficult to see objects that are far away)
  7. Oral candidiasis (fungal infection of mouth)
  8. Oral herpes (viral infection of mouth)
  9. Upper respiratory tract infection
  10. Vision blurred

What are the existing conditions these people have? *

  1. High Blood Pressure: 9 people, 69.23%
  2. Malignant Melanoma (skin cancer rises from melancytes): 9 people, 69.23%
  3. Back Pain: 6 people, 46.15%
  4. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 4 people, 30.77%
  5. Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 30.77%
  6. Fever: 4 people, 30.77%
  7. Metastases To Central Nervous System (cancer spreads to central nervous system): 4 people, 30.77%
  8. Constipation: 4 people, 30.77%
  9. Neoplasm Malignant (cancer tumour): 4 people, 30.77%
  10. Rashes (redness): 4 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take Paracetamol and Dermatop?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paracetamol and Dermatop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paracetamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dermatop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paracetamol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dermatop and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen and prednicarbate (the active ingredients of Paracetamol and Dermatop, respectively), and Paracetamol and Dermatop (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: